HLB파나진

046210KOSDAQ

57.3 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment21.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 4.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HLB Panajin is a specialized biotech venture company focusing on PNA (Peptide Nucleic Acid)-based bio materials and molecular diagnostics. The company develops and commercializes diverse diagnostic products, including somatic mutation detection, liquid biopsy, and automated diagnostic technologies, leveraging its PNA platform. Its subsidiary, BioSquare, expands into immunoassay technologies, while the company aims to build an AI-based diagnostic platform and develop PNA-based therapeutics for comprehensive healthcare solutions.

Number of Employees

84people

Average Salary

51.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.73Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

-4.21Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

2.48Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼63.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -5.8% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Positive
HLB파나진, 美 컨퍼런스서 인공핵산 소개…글로벌 신약 확장
HLB파나진의 인공핵산(PNA) 기술이 글로벌 컨퍼런스에서 소개되며 신약 개발 및 확장 가능성에 대한 긍정적인 평가를 받았다.
Positive
HLB파나진, 상반기 영업익 5억…2년 연속 영업흑자
HLB파나진이 상반기에 매출과 영업이익을 달성하며 2년 연속 흑자를 기록, 특히 핵산치료제 시장 성장에 대응하는 PNA 소재 사업 확장에 성공했다.
Positive
HLB파마진, 글로벌 컨퍼런스서 PNA 기조발표…기술 경쟁력·확장성 소...
HLB파나진의 글로벌 컨퍼런스 기조발표를 통해 기술 경쟁력과 확장성을 강조하며 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 1,155Won52-week high 2,65052-week low 999

1-month return4.0Point

1m +4.43% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-08-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-27
Neutral반기보고서 (2026.06)2026-08-14
Neutral주식등의대량보유상황보고서(일반)2026-08-13